Major Seafood Recall: Uneviscerated Fish Linked to Health Risks

The Food and Drug Administration (FDA) has announced a significant recall of a seafood product made by New Hoque & Sons Inc., located in Maspeth, New York. The company is recalling its “Dry Ghoinnya Fish” after it was discovered that the fish had not undergone proper processing, leaving internal organs intact. This serious health violation poses a risk of botulism, an illness that can lead to severe medical complications.

Health Risks and Regulatory Violations

According to the FDA, the sale of uneviscerated fish is illegal under New York State Agriculture and Markets regulations. The presence of internal organs increases the likelihood of Clostridium botulinum spores, which can lead to botulism poisoning. Symptoms of this potentially fatal illness include dizziness, blurred vision, difficulty speaking or swallowing, and muscle weakness. In extreme cases, it can result in respiratory failure.

The recalled fish was distributed nationwide in retail stores, packaged in clear plastic bags weighing between 10 to 12 pounds. Each package bears an expiration date of May 19, 2025, and has a UPC code of 908172635412. Inspectors from the New York State Department of Agriculture and Markets uncovered the uneviscerated fish during routine checks, emphasizing the importance of food safety protocols.

Consumer Guidance and Next Steps

As of now, no illnesses related to this recall have been reported. However, health officials are urging consumers who have purchased the “Dry Ghoinnya Fish” to return it to the point of purchase for a full refund. The FDA encourages anyone who experiences symptoms associated with botulism to seek immediate medical attention.

Consumers with further questions can reach out to New Hoque & Sons Inc. at (718) 391-0992. The recall serves as a reminder of the critical need for stringent food safety measures to protect public health and prevent potential outbreaks.